NumerixS Investment Technologies’s Global Blood Therapeutics, Inc. GBT Stock Holding History

NumerixS Investment Technologies’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,200	Closed	-$63K	–	1307
2019 Q2	$63K	Buy	+1,200	New	+$69K	0.02%	722
2018 Q4	–	Sell	-20,000	Closed	-$763K	–	1475
2018 Q3	$763K	Buy	+20,000	New	+$886K	0.14%	200
2017 Q3	–	Sell	-2,900	Closed	-$79K	–	1406
2017 Q2	$79K	Buy	+2,900	New	+$86.3K	0.01%	878
2017 Q1	–	Sell	-900	Closed	-$13K	–	1436
2016 Q4	$13K	Sell	900 -11,469	-93%	-$201K	﹤0.01%	1054
2016 Q3	$285K	Buy	+12,369	New	+$236K	0.04%	567

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

NumerixS Investment Technologies's GBT Position: Q3 2019 in Review

NumerixS Investment Technologies sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2019, closing a stake of 1,200 shares — an estimated $63K sold.

NumerixS Investment Technologies first reported a position in GBT in Q3 2016 and held it in 5 quarters. The position peaked at $763K in Q3 2018. 208 funds tracked by Wall St. Rank hold GBT as of Q3 2019.

NumerixS Investment Technologies reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
NumerixS Investment Technologies sold 1,200 Global Blood Therapeutics, Inc. shares in Q3 2019, an estimated $63K.
NumerixS Investment Technologies first reported a position in Global Blood Therapeutics, Inc. in Q3 2016 and held it in 5 quarters.
NumerixS Investment Technologies's Global Blood Therapeutics, Inc. position peaked at $763K in Q3 2018.
208 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2019.

Based on NumerixS Investment Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.